Solventum Corporation

US$90.38As of Sun 8 Nov 2026, 12:00 UTC
NYSE:SOLVHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR 10.57%
Div yield —
ROE 3.19%
Medical Instruments & Supplies
Beta (5Y) 0.75
PE TTM 100.4
TSR TTM 30.91%
Mkt cap US$15.34B
ROIC 4.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$93
3.39%
200.39%
Hold 9|1|1|4|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.85
0.84
0.87
0.83
(1.42%)
(4.92%)
(4.05%)
(6.69%)
Revenue$M
905.6
935.2
919.8
917.1
6.69%
8.66%
7.72%
5.21%
Peers (US$15.34B)
Cap (US$)
PE
11.70B
24.17x
15.79B
61.10x
Capital
TTM
5Y
10Y
Leveragex
0.262
0.444
0.444
EBIT/Intx
1.166
0.302
0.245
Own earn%
(40.58)
69.84
72.76
Sh yield%
16.02
34.28
38.38
Owners
Insiders/Inst%
14.26
59.60
Short interest%
4.05
SBC / revenue%
0.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
4–11
$1 testx
—
Incr. ROIC%
1